Pretax income is the income that a company earns before paying income taxes. Tandem Diabetes Care's pretax income for the
three
months ended in Dec. 2023 was $-31.3 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-220.3 Mil.
Tandem Diabetes Care's pretax margin was -15.91%.
During the past 13 years, Tandem Diabetes Care's highest Pretax Margin was 2.26%. The lowest was -159.79%. And the median was -48.06%.
Tandem Diabetes Care Pre-Tax Income Historical Data
The historical data trend for Tandem Diabetes Care's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tandem Diabetes Care's Pre-Tax Income
For the Medical Devices subindustry, Tandem Diabetes Care's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tandem Diabetes Care's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Tandem Diabetes Care's Pre-Tax Income falls into.
Tandem Diabetes Care Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Tandem Diabetes Care's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-220.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care (NAS:TNDM) Pre-Tax Income Explanation
Tandem Diabetes Care's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Tandem Diabetes Care's highest Pretax Margin was 2.26%. The lowest was -159.79%. And the median was -48.06%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Tandem Diabetes Care's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Tandem Diabetes Care (Tandem Diabetes Care) Business Description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNDM has been successfully added to your 